Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines
- PMID: 33533893
- DOI: 10.1001/jama.2021.1375
Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines
Similar articles
-
Could mixing COVID vaccines boost immune response?Nature. 2021 Feb;590(7846):375-376. doi: 10.1038/d41586-021-00315-5. Nature. 2021. PMID: 33547431 No abstract available.
-
UK science advisers: publish evidence behind COVID vaccine changes.Nature. 2021 Jan;589(7841):169-170. doi: 10.1038/d41586-021-00045-8. Nature. 2021. PMID: 33437064 No abstract available.
-
How can countries stretch COVID vaccine supplies? Scientists are divided over dosing strategies.Nature. 2021 Jan;589(7841):182. doi: 10.1038/d41586-021-00001-6. Nature. 2021. PMID: 33437062 No abstract available.
-
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877. Eur Rev Med Pharmacol Sci. 2021. PMID: 33629336 Review.
-
SARS-CoV-2: Unique Challenges of the Virus and Vaccines.Immunol Invest. 2021 Oct;50(7):802-809. doi: 10.1080/08820139.2021.1936009. Epub 2021 Jun 10. Immunol Invest. 2021. PMID: 34109900 Free PMC article. Review.
Cited by
-
Efficacy of antibody response following the vaccination of SARS-CoV-2 infected and noninfected healthcare workers by two-dose inactive vaccine against COVID-19.J Med Virol. 2022 Jun;94(6):2431-2437. doi: 10.1002/jmv.27649. Epub 2022 Feb 14. J Med Virol. 2022. PMID: 35128700 Free PMC article.
-
Should we allocate more COVID-19 vaccine doses to non-vaccinated individuals?PLOS Glob Public Health. 2022 Jul 1;2(7):e0000498. doi: 10.1371/journal.pgph.0000498. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962342 Free PMC article.
-
Vaccine efficacy in mutant SARS-CoV-2 variants.Int J Cell Biol Physiol. 2021;4(1-2):1-12. Epub 2021 Oct 13. Int J Cell Biol Physiol. 2021. PMID: 34790972 Free PMC article.
-
Vaccines and Therapeutics for COVID-19 - How Can Understanding SARS-CoV-2 Glycosylation Lead to Pharmaceutical Advances?Am Pharm Rev. 2021 May-Jun;24(4):14-21. Epub 2021 Jun 16. Am Pharm Rev. 2021. PMID: 38099300 Free PMC article.
-
Development of an Oral Salmonella-Based Vaccine Platform against SARS-CoV-2.Vaccines (Basel). 2022 Jan 1;10(1):67. doi: 10.3390/vaccines10010067. Vaccines (Basel). 2022. PMID: 35062728 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical